Dr Michael Winlo sat down with Emma Koehn from the Sydney Morning Herald to discuss the future of psychedelics and what the biotech industry is doing to unlock their potential to alleviate the rising mental health problem in Australia.

““We still need to establish a reliable supply of ‘pharmaceutical quality’ products and, more importantly, clinical services with the appropriate facilities and sufficiently trained and vetted staff,” he said

Read the article here